Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
4
×
boston blog main
boston top stories
life sciences
national blog main
deals
national top stories
san francisco blog main
alnylam pharmaceuticals
biotech
clinical trials
crispr
gene editing
rna interference
startups
vc
abbvie
alexion pharmaceuticals
allergan
alzheimer's disease
amy schulman
andreas klein
anna greka
barry greene
boehringer ingelheim
car-t
caron jacobson
cigall kadoch
craig mello
cynthia collins
dan ollendorf
david walt
diagnostics
dicerna pharamceuticals
editas medicine
events
fda
feng zhang
foghorn therapeutics
gene therapy
What
gene
4
×
medicines
4
×
editing
research
abbvie
alliance
aren’t
bio
biotech
car
caught
causing
create
crispr
cutting
diagnostic
dicerna
disease
diseases
drug
edge
editas
exits
experimental
experiments
eye
fix
genetic
heats
hepatitis
high
hot
human
intended
interference
launch
launches
market
pact
partnership
Language
unset
Current search:
boston
×
medicines
×
gene
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”
